Lu-Hsuan Wu Ph.D. , Ching-Lan Cheng Ph.D. , Yea-Huei Kao Yang BS Pharm. , Swu-Jane Lin Ph.D.
{"title":"A Nationwide Cohort Study on Antidepressant Use and Stroke Risk in Young Adults Aged 18–44 Years","authors":"Lu-Hsuan Wu Ph.D. , Ching-Lan Cheng Ph.D. , Yea-Huei Kao Yang BS Pharm. , Swu-Jane Lin Ph.D.","doi":"10.1016/j.clinthera.2025.06.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Although serious adverse reactions to antidepressants, including stroke, are rare, they have gained increased attention. Many patients start antidepressant treatment at a young age, yet stroke risk among them remains understudied. This study aimed to assess stroke risk associated with antidepressant use across age groups, antidepressant classes, and treatment indications.</div></div><div><h3>Methods</h3><div>We conducted a cohort study using a new user approach, including adults aged 18–44 years in 2018. Overall, 119,751 antidepressant users and 119,751 non-users were matched by age, sex, and date of treatment initiation. Antidepressants, classified as N06A in the WHO Anatomical Therapeutic Chemical Classification System, were selected. The primary endpoint was the first stroke event within 180 days of treatment initiation.</div></div><div><h3>Finding</h3><div>Antidepressant use was associated with an increased stroke risk (hazard ratio [HR], 4.33; 95% confidence interval [CI] 2.30–8.14), particularly ischemic stroke (HR, 7.02; 95% CI 3.18–15.49), than hemorrhagic stroke (HR, 1.63; 95% CI 0.60–4.39). Elevated stroke risk was observed among users of tricyclic antidepressants and serotonin antagonist and reuptake inhibitors but not among users of selective serotonin or serotonin-norepinephrine reuptake inhibitors. A significantly higher stroke risk was noted among antidepressant users without psychiatric disorders (HR, 5.47; 95% CI, 2.58–11.61) or neurological disorders (HR, 4.10; 95% CI, 2.12–7.95) than among non-users.</div></div><div><h3>Implications</h3><div>Antidepressant use was associated with increased stroke risk in adults aged 18–44 years. However, the findings were limited by potential biases in administrative data and a lack of adjustment for socioeconomic and geographic disparities.</div></div>","PeriodicalId":10699,"journal":{"name":"Clinical therapeutics","volume":"47 9","pages":"Pages 720-728"},"PeriodicalIF":3.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical therapeutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0149291825002206","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Although serious adverse reactions to antidepressants, including stroke, are rare, they have gained increased attention. Many patients start antidepressant treatment at a young age, yet stroke risk among them remains understudied. This study aimed to assess stroke risk associated with antidepressant use across age groups, antidepressant classes, and treatment indications.
Methods
We conducted a cohort study using a new user approach, including adults aged 18–44 years in 2018. Overall, 119,751 antidepressant users and 119,751 non-users were matched by age, sex, and date of treatment initiation. Antidepressants, classified as N06A in the WHO Anatomical Therapeutic Chemical Classification System, were selected. The primary endpoint was the first stroke event within 180 days of treatment initiation.
Finding
Antidepressant use was associated with an increased stroke risk (hazard ratio [HR], 4.33; 95% confidence interval [CI] 2.30–8.14), particularly ischemic stroke (HR, 7.02; 95% CI 3.18–15.49), than hemorrhagic stroke (HR, 1.63; 95% CI 0.60–4.39). Elevated stroke risk was observed among users of tricyclic antidepressants and serotonin antagonist and reuptake inhibitors but not among users of selective serotonin or serotonin-norepinephrine reuptake inhibitors. A significantly higher stroke risk was noted among antidepressant users without psychiatric disorders (HR, 5.47; 95% CI, 2.58–11.61) or neurological disorders (HR, 4.10; 95% CI, 2.12–7.95) than among non-users.
Implications
Antidepressant use was associated with increased stroke risk in adults aged 18–44 years. However, the findings were limited by potential biases in administrative data and a lack of adjustment for socioeconomic and geographic disparities.
期刊介绍:
Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.